CD276 and neoplasm: Twenty-one different antibodies were used to capture and phenotype the exosomes for both the general exosomer markers, membrane markers (e.g. PLAP, HLA-ABC) and tumour-associated antigens (e.g. EpCam, HER2, CD276 [B7H3]).